论文部分内容阅读
目的探讨稳心颗粒与胺碘酮治疗慢性心力衰竭合并室性早搏的疗效观察。方法将本院2015年1月至2016年6月期间接收的慢性心力衰竭合并室性早搏患者的临床资料进行回顾性研究,将其分为2组:联合组(稳心颗粒联合胺碘酮组)患者52例,传统组(单用胺碘酮组)患者52例,对这两组患者治疗的总有效率以及射血分数的改善进行比较。结果两组患者室性早搏的次数、射血分数、运动耐量均有明显改善,联合组治疗总有效率为94.23%,传统组治疗总有效率为78.85%,联合组治疗总有效率明显优于传统组,差异具有统计学意义(P<0.05)。结论稳心颗粒联合胺碘酮治疗慢性心力衰竭合并室性早搏患者,临床疗效显著,可有效改善射血分数和活动耐力,值得临床推广使用。
Objective To investigate the curative effect of Wenxin granule and amiodarone in treating chronic heart failure combined with ventricular premature beats. Methods The clinical data of patients with chronic heart failure complicated with premature ventricular contractions received from January 2015 to June 2016 in our hospital were retrospectively studied. They were divided into two groups: combination group (Wenxin Granule combined with amiodarone group ) Were compared with 52 patients in the traditional group (52 patients in the amiodarone alone group), the overall efficacy of treatment and the improvement of ejection fraction in both groups. Results The frequency of ventricular premature beats, ejection fraction and exercise tolerance were significantly improved in both groups. The total effective rate was 94.23% in the combination group and 78.85% in the traditional group. The total effective rate in the combined group was significantly better than that in the combined group The traditional group, the difference was statistically significant (P <0.05). Conclusion Wenxin granule combined with amiodarone in patients with chronic heart failure complicated with premature ventricular contraction has significant clinical effect, which can effectively improve ejection fraction and endurance, and is worthy of clinical promotion.